Leaflet HALOPERIDOL ARENA 2mg / ml oral drops solution

Indicated for: schizophrenia; bipolar disorder

Route of administration: oral

Substance: haloperidol (antipsychotic)

ATC: N05AD01 (Nervous system | Antipsychotics | Butyrophenone derivatives)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Haloperidol is an antipsychotic medication from the butyrophenone class, used to treat severe mental disorders such as schizophrenia, bipolar disorder, and acute psychotic episodes. It is also used to control severe agitation, aggressive behavior, and tics associated with Tourette syndrome.

Haloperidol works by blocking dopamine receptors in the brain, helping to reduce symptoms such as hallucinations, delusions, and disorganized thinking. It is also effective in reducing severe nausea and vomiting, particularly in the context of cancer treatments.

Side effects may include drowsiness, muscle stiffness, tremors, dizziness, or an increased risk of extrapyramidal symptoms (involuntary movements). In rare cases, it can cause neuroleptic malignant syndrome, a serious condition. It is important for the medication to be administered under strict medical supervision.

General data about HALOPERIDOL ARENA 2mg / ml

  • Substance: haloperidol
  • Date of latest medicines list: 01-06-2026
  • Product code: W61980001
  • Concentration: 2mg / ml
  • Pharmaceutical form: oral drops solution
  • Quantity: 1
  • Product type: Generic medicine
  • Price: 9.00 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: MEDUMAN S.A. - ROMANIA
  • Holder: ARENA GROUP S.A. - ROMANIA
  • Number: 13424/2020/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-1 luna

Pharmaceutical forms available for haloperidol

Concentrations available for haloperidol

  • 0.5mg
  • 1mg
  • 2mg
  • 2mg/ml
  • 50mg/ml
  • 5mg
  • 5mg/ml

Other substances similar to haloperidol

Compensation lists for HALOPERIDOL ARENA 2mg / ml Arena

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

9.00 RON

8.04 RON

0.96 RON

G15 (C1) - Mental disorders

Price

Copayment

Patient

9.00 RON

9.00 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

9.00 RON

9.00 RON

0.00 RON